IgE receptors on human basophils. Relationship to serum IgE concentration.
about
The pharmacological basis of anti-IgE therapyTGF-beta 1 inhibits mast cell Fc epsilon RI expressionHalf-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.Regulation of the high affinity IgE receptor (Fc epsilonRI) in human neutrophils: role of seasonal allergen exposure and Th-2 cytokines.Skewed Exposure to Environmental Antigens Complements Hygiene Hypothesis in Explaining the Rise of AllergyRelationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population.Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.Saturation of immunoglobulin E (IgE) binding sites by polyclonal IgE does not explain the protective effect of helminth infections against atopy.Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders.Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells?Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions.Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels.Molecular versatility of antibodies.Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm).IL-4 and TGF-beta 1 counterbalance one another while regulating mast cell homeostasis.Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state.Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions.Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance.Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells.Mast cells and mastocytosis.Rabaptin-5 regulates receptor expression and functional activation in mast cells.Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseasesLymphocytes with immunoglobulin E Fc receptors in patients with atopic disordersExpression of the high affinity IgE receptor by neutrophils of individuals with allergic asthma is both minimal and insensitive to regulation by serum IgE.Suspension culture of human mast cells/basophils from umbilical cord blood mononuclear cellsNasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells.CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.Emerging functions of basophils in protective and allergic immune responses.Cbl family proteins: balancing FcεRI-mediated mast cell and basophil activation.Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation.Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm.Diagnosis of allergy: in vitro testing.Omalizumab for severe asthma: efficacy beyond the atopic patient?Changing patterns of antigen exposure and their impact on the prevalence of allergy.Systems biology of ovine intestinal parasite resistance: disease gene modules and biomarkers.Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study.
P2860
Q28143946-CD9B7E0D-83FE-4282-969B-49EE28C628BBQ28587575-2A6570CF-C0CB-469B-806B-4F13EAC69EECQ30276181-05D22DDE-F415-40DC-B693-1BEDDE77BE10Q33326647-7CE092B7-6073-49FD-925A-FBBD72B858D2Q33639328-4C835987-B48D-40A9-8C99-A2226E947186Q33680926-0DDFABEB-FE69-461C-B19C-6EA41125776AQ33850604-D955062F-9F1B-4AAF-83A8-115F9F076928Q33883393-C95AA3DE-E43C-4A8B-B510-426EF30F4D18Q34101369-64E392BE-64F1-4B33-BA65-48AB9A336669Q34492595-5F476A8E-8FAD-44B2-8F2D-04591DA37F9AQ34508253-4F28ADF7-D9C4-4686-A72E-F75E374A8ACCQ34563422-600B9AEC-D27F-408A-BF2B-14C7B97C8CA4Q34576338-730466E3-5749-49B6-AF1F-9E3B1797019FQ34792467-2101D6D0-A063-4094-BE9C-4482E6B36508Q35065055-756F019E-EE90-4F52-8557-C57C0361F53AQ35774220-737882BD-94D7-46EF-B4F4-613652AFAAEBQ35919517-84B1BBD1-891E-4DA2-937D-30702C5EE38CQ36068095-9CB5DD25-FD2B-432F-8F67-8301679BC554Q36158825-12E3806A-0B5F-48CF-B61A-CB819CE1E526Q36229717-3D03E5A8-3883-47B4-BC00-E2707D9D4487Q36376804-12425DAE-0F8C-45E8-B7BA-FE5FC5050C1FQ36385111-F9918B82-3569-4C66-94DC-D6B503E526D9Q36677451-B43AC1FE-BF9A-4968-8765-B1B0A291375CQ36835143-1CFDDF75-79C8-4685-A903-CB594CF7B971Q36969840-02F9A54C-BA27-49CE-8189-FA6BF3713947Q36983081-6A729458-B6C1-4B53-A7FE-878374F7889FQ37041210-70EAB2EF-D7B1-4F19-A7F2-BE4271ED9A97Q37337010-B08681C7-9311-4ED6-81F5-3DFA63AD50A3Q37343174-50C4C027-A84A-408C-925D-5E4ABB4A1827Q37365477-830606BE-DCBD-4D13-BE63-05B6E5F8ED4EQ37660379-DE287B84-6AB7-42DC-A745-AC506A9E4566Q37673990-5263A3E9-3FBD-453A-86D5-0B7C58EF3A17Q37859217-27878F9D-EF5A-4FA9-B609-F0673745B723Q37963481-20D1B71F-8715-4B59-81FA-40F8E8E6246FQ37965363-D4B7F976-A191-46CA-A303-49159A279839Q38164717-A9BDB560-06CD-4086-A1A3-72AC51CEC58DQ38201304-3A93574A-7A54-4F02-BEDC-7178DC9B742DQ38265966-23F0B3ED-81D4-4C46-936C-5A6CE067D01CQ38339429-1841E3E1-D025-499C-B5A3-F2E7BC9752E4Q38396322-1EF2F780-0DE1-4897-97B3-FA622C0A2CB2
P2860
IgE receptors on human basophils. Relationship to serum IgE concentration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IgE receptors on human basophils. Relationship to serum IgE concentration.
@en
IgE receptors on human basophils. Relationship to serum IgE concentration.
@nl
type
label
IgE receptors on human basophils. Relationship to serum IgE concentration.
@en
IgE receptors on human basophils. Relationship to serum IgE concentration.
@nl
prefLabel
IgE receptors on human basophils. Relationship to serum IgE concentration.
@en
IgE receptors on human basophils. Relationship to serum IgE concentration.
@nl
P2093
P2860
P356
P1476
IgE receptors on human basophils. Relationship to serum IgE concentration.
@en
P2093
Adkinson NF Jr
Lichtenstein LM
Malveaux FJ
P2860
P304
P356
10.1172/JCI109103
P407
P577
1978-07-01T00:00:00Z